nodes	percent_of_prediction	percent_of_DWPC	metapath
Dasatinib—FMO3—metabolic syndrome X	0.688	1	CbGaD
Dasatinib—PDGFRA—penis—metabolic syndrome X	0.0039	0.0354	CbGeAlD
Dasatinib—RIPK2—endothelium—metabolic syndrome X	0.00208	0.0189	CbGeAlD
Dasatinib—RIPK2—blood vessel—metabolic syndrome X	0.00192	0.0174	CbGeAlD
Dasatinib—EPHB1—kidney—metabolic syndrome X	0.00179	0.0163	CbGeAlD
Dasatinib—SRC—artery—metabolic syndrome X	0.00177	0.0161	CbGeAlD
Dasatinib—EPHB4—endothelium—metabolic syndrome X	0.00176	0.016	CbGeAlD
Dasatinib—MAPK14—blood vessel—metabolic syndrome X	0.00171	0.0155	CbGeAlD
Dasatinib—EPHB4—blood vessel—metabolic syndrome X	0.00162	0.0147	CbGeAlD
Dasatinib—EPHB1—adipose tissue—metabolic syndrome X	0.00161	0.0147	CbGeAlD
Dasatinib—JAK2—blood vessel—metabolic syndrome X	0.00161	0.0146	CbGeAlD
Dasatinib—EPHA2—blood vessel—metabolic syndrome X	0.00159	0.0145	CbGeAlD
Dasatinib—BMX—cardiovascular system—metabolic syndrome X	0.00154	0.014	CbGeAlD
Dasatinib—SRC—endothelium—metabolic syndrome X	0.00149	0.0136	CbGeAlD
Dasatinib—Nail disorder—Metformin—metabolic syndrome X	0.00145	0.0523	CcSEcCtD
Dasatinib—TEC—liver—metabolic syndrome X	0.00144	0.0131	CbGeAlD
Dasatinib—SRMS—kidney—metabolic syndrome X	0.00144	0.0131	CbGeAlD
Dasatinib—SIK2—adipose tissue—metabolic syndrome X	0.00143	0.013	CbGeAlD
Dasatinib—SRC—blood vessel—metabolic syndrome X	0.00138	0.0125	CbGeAlD
Dasatinib—STAT5B—cardiovascular system—metabolic syndrome X	0.00136	0.0124	CbGeAlD
Dasatinib—BMX—adipose tissue—metabolic syndrome X	0.00136	0.0123	CbGeAlD
Dasatinib—STAT5B—kidney—metabolic syndrome X	0.00133	0.0121	CbGeAlD
Dasatinib—KIT—endothelium—metabolic syndrome X	0.00122	0.0111	CbGeAlD
Dasatinib—STAT5B—adipose tissue—metabolic syndrome X	0.0012	0.0109	CbGeAlD
Dasatinib—ZAK—cardiovascular system—metabolic syndrome X	0.00114	0.0104	CbGeAlD
Dasatinib—EPHB1—liver—metabolic syndrome X	0.00113	0.0103	CbGeAlD
Dasatinib—KIT—blood vessel—metabolic syndrome X	0.00112	0.0102	CbGeAlD
Dasatinib—EPHA3—adipose tissue—metabolic syndrome X	0.00111	0.0101	CbGeAlD
Dasatinib—PDGFRB—blood vessel—metabolic syndrome X	0.0011	0.00998	CbGeAlD
Dasatinib—Contusion—Metformin—metabolic syndrome X	0.00108	0.0389	CcSEcCtD
Dasatinib—SIK3—adipose tissue—metabolic syndrome X	0.00108	0.00982	CbGeAlD
Dasatinib—ZAK—adipose tissue—metabolic syndrome X	0.001	0.00913	CbGeAlD
Dasatinib—SIK2—liver—metabolic syndrome X	0.000999	0.00909	CbGeAlD
Dasatinib—FRK—liver—metabolic syndrome X	0.000974	0.00885	CbGeAlD
Dasatinib—BMPR1B—adipose tissue—metabolic syndrome X	0.000963	0.00875	CbGeAlD
Dasatinib—BTK—adipose tissue—metabolic syndrome X	0.000958	0.00871	CbGeAlD
Dasatinib—TNK2—adipose tissue—metabolic syndrome X	0.000944	0.00858	CbGeAlD
Dasatinib—CSK—cardiovascular system—metabolic syndrome X	0.000922	0.00838	CbGeAlD
Dasatinib—CSK—kidney—metabolic syndrome X	0.000902	0.0082	CbGeAlD
Dasatinib—TESK1—adipose tissue—metabolic syndrome X	0.000888	0.00807	CbGeAlD
Dasatinib—Neuropathy—Metformin—metabolic syndrome X	0.000886	0.0319	CcSEcCtD
Dasatinib—STK36—adipose tissue—metabolic syndrome X	0.000873	0.00794	CbGeAlD
Dasatinib—RIPK2—cardiovascular system—metabolic syndrome X	0.000856	0.00778	CbGeAlD
Dasatinib—LIMK2—adipose tissue—metabolic syndrome X	0.000844	0.00768	CbGeAlD
Dasatinib—STAT5B—liver—metabolic syndrome X	0.000842	0.00766	CbGeAlD
Dasatinib—STK35—adipose tissue—metabolic syndrome X	0.000818	0.00744	CbGeAlD
Dasatinib—SIK1—kidney—metabolic syndrome X	0.000818	0.00743	CbGeAlD
Dasatinib—CSK—adipose tissue—metabolic syndrome X	0.000813	0.00739	CbGeAlD
Dasatinib—HCK—adipose tissue—metabolic syndrome X	0.000803	0.0073	CbGeAlD
Dasatinib—ERBB3—kidney—metabolic syndrome X	0.000801	0.00729	CbGeAlD
Dasatinib—ABL2—adipose tissue—metabolic syndrome X	0.000798	0.00725	CbGeAlD
Dasatinib—MAPK14—cardiovascular system—metabolic syndrome X	0.000763	0.00693	CbGeAlD
Dasatinib—FGR—cardiovascular system—metabolic syndrome X	0.00076	0.00691	CbGeAlD
Dasatinib—SIK3—liver—metabolic syndrome X	0.000757	0.00689	CbGeAlD
Dasatinib—RIPK2—adipose tissue—metabolic syndrome X	0.000755	0.00686	CbGeAlD
Dasatinib—MAPK14—kidney—metabolic syndrome X	0.000746	0.00679	CbGeAlD
Dasatinib—SIK1—adipose tissue—metabolic syndrome X	0.000737	0.0067	CbGeAlD
Dasatinib—EPHA4—adipose tissue—metabolic syndrome X	0.00073	0.00663	CbGeAlD
Dasatinib—EPHB4—cardiovascular system—metabolic syndrome X	0.000723	0.00657	CbGeAlD
Dasatinib—ERBB3—adipose tissue—metabolic syndrome X	0.000722	0.00657	CbGeAlD
Dasatinib—JAK2—cardiovascular system—metabolic syndrome X	0.000718	0.00653	CbGeAlD
Dasatinib—MAP3K2—adipose tissue—metabolic syndrome X	0.000715	0.0065	CbGeAlD
Dasatinib—EPHA2—cardiovascular system—metabolic syndrome X	0.000709	0.00645	CbGeAlD
Dasatinib—FYN—cardiovascular system—metabolic syndrome X	0.000708	0.00644	CbGeAlD
Dasatinib—EPHB4—kidney—metabolic syndrome X	0.000707	0.00643	CbGeAlD
Dasatinib—ZAK—liver—metabolic syndrome X	0.000704	0.0064	CbGeAlD
Dasatinib—JAK2—kidney—metabolic syndrome X	0.000703	0.00639	CbGeAlD
Dasatinib—FYN—kidney—metabolic syndrome X	0.000693	0.0063	CbGeAlD
Dasatinib—MAP3K3—cardiovascular system—metabolic syndrome X	0.000692	0.00629	CbGeAlD
Dasatinib—LYN—liver—metabolic syndrome X	0.000685	0.00623	CbGeAlD
Dasatinib—MAPK14—adipose tissue—metabolic syndrome X	0.000673	0.00612	CbGeAlD
Dasatinib—BTK—liver—metabolic syndrome X	0.000672	0.00611	CbGeAlD
Dasatinib—FGR—adipose tissue—metabolic syndrome X	0.00067	0.00609	CbGeAlD
Dasatinib—LCK—adipose tissue—metabolic syndrome X	0.00067	0.00609	CbGeAlD
Dasatinib—TNK2—liver—metabolic syndrome X	0.000662	0.00602	CbGeAlD
Dasatinib—FMO3—adipose tissue—metabolic syndrome X	0.000647	0.00588	CbGeAlD
Dasatinib—EPHB4—adipose tissue—metabolic syndrome X	0.000638	0.0058	CbGeAlD
Dasatinib—JAK2—adipose tissue—metabolic syndrome X	0.000633	0.00576	CbGeAlD
Dasatinib—PDGFRA—cardiovascular system—metabolic syndrome X	0.000627	0.0057	CbGeAlD
Dasatinib—EPHA2—adipose tissue—metabolic syndrome X	0.000626	0.00569	CbGeAlD
Dasatinib—YES1—kidney—metabolic syndrome X	0.000625	0.00569	CbGeAlD
Dasatinib—FYN—adipose tissue—metabolic syndrome X	0.000624	0.00568	CbGeAlD
Dasatinib—TESK1—liver—metabolic syndrome X	0.000622	0.00566	CbGeAlD
Dasatinib—Breast disorder—Metformin—metabolic syndrome X	0.000619	0.0223	CcSEcCtD
Dasatinib—SRC—cardiovascular system—metabolic syndrome X	0.000615	0.00559	CbGeAlD
Dasatinib—STK36—liver—metabolic syndrome X	0.000613	0.00557	CbGeAlD
Dasatinib—MAP4K5—adipose tissue—metabolic syndrome X	0.00061	0.00555	CbGeAlD
Dasatinib—MAP3K3—adipose tissue—metabolic syndrome X	0.00061	0.00555	CbGeAlD
Dasatinib—SRC—kidney—metabolic syndrome X	0.000602	0.00547	CbGeAlD
Dasatinib—Abdominal distension—Metformin—metabolic syndrome X	0.000596	0.0214	CcSEcCtD
Dasatinib—LIMK2—liver—metabolic syndrome X	0.000592	0.00538	CbGeAlD
Dasatinib—EPHB6—adipose tissue—metabolic syndrome X	0.000583	0.0053	CbGeAlD
Dasatinib—Pancreatitis—Metformin—metabolic syndrome X	0.00058	0.0209	CcSEcCtD
Dasatinib—Angina pectoris—Metformin—metabolic syndrome X	0.000576	0.0207	CcSEcCtD
Dasatinib—STK35—liver—metabolic syndrome X	0.000574	0.00522	CbGeAlD
Dasatinib—CSK—liver—metabolic syndrome X	0.00057	0.00518	CbGeAlD
Dasatinib—MAP2K5—cardiovascular system—metabolic syndrome X	0.000566	0.00514	CbGeAlD
Dasatinib—YES1—adipose tissue—metabolic syndrome X	0.000564	0.00512	CbGeAlD
Dasatinib—HCK—liver—metabolic syndrome X	0.000563	0.00512	CbGeAlD
Dasatinib—ABL2—liver—metabolic syndrome X	0.000559	0.00509	CbGeAlD
Dasatinib—Neutropenia—Metformin—metabolic syndrome X	0.000553	0.0199	CcSEcCtD
Dasatinib—PDGFRA—adipose tissue—metabolic syndrome X	0.000553	0.00503	CbGeAlD
Dasatinib—CSF1R—cardiovascular system—metabolic syndrome X	0.000552	0.00502	CbGeAlD
Dasatinib—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.00055	0.0198	CcSEcCtD
Dasatinib—SRC—adipose tissue—metabolic syndrome X	0.000542	0.00493	CbGeAlD
Dasatinib—RIPK2—liver—metabolic syndrome X	0.000529	0.00481	CbGeAlD
Dasatinib—Infestation—Metformin—metabolic syndrome X	0.000528	0.019	CcSEcCtD
Dasatinib—Infestation NOS—Metformin—metabolic syndrome X	0.000528	0.019	CcSEcCtD
Dasatinib—Neuropathy peripheral—Metformin—metabolic syndrome X	0.000517	0.0186	CcSEcCtD
Dasatinib—SIK1—liver—metabolic syndrome X	0.000517	0.0047	CbGeAlD
Dasatinib—ERBB3—liver—metabolic syndrome X	0.000507	0.00461	CbGeAlD
Dasatinib—MAP3K2—liver—metabolic syndrome X	0.000502	0.00456	CbGeAlD
Dasatinib—KIT—cardiovascular system—metabolic syndrome X	0.000501	0.00456	CbGeAlD
Dasatinib—Hepatobiliary disease—Metformin—metabolic syndrome X	0.000499	0.018	CcSEcCtD
Dasatinib—MAP2K5—adipose tissue—metabolic syndrome X	0.000499	0.00453	CbGeAlD
Dasatinib—KIT—kidney—metabolic syndrome X	0.00049	0.00446	CbGeAlD
Dasatinib—PDGFRB—cardiovascular system—metabolic syndrome X	0.00049	0.00445	CbGeAlD
Dasatinib—CSF1R—adipose tissue—metabolic syndrome X	0.000487	0.00443	CbGeAlD
Dasatinib—PDGFRB—kidney—metabolic syndrome X	0.000479	0.00435	CbGeAlD
Dasatinib—Hepatitis—Metformin—metabolic syndrome X	0.000474	0.017	CcSEcCtD
Dasatinib—MAPK14—liver—metabolic syndrome X	0.000472	0.00429	CbGeAlD
Dasatinib—FGR—liver—metabolic syndrome X	0.00047	0.00427	CbGeAlD
Dasatinib—LCK—liver—metabolic syndrome X	0.00047	0.00427	CbGeAlD
Dasatinib—Oedema peripheral—Metformin—metabolic syndrome X	0.000467	0.0168	CcSEcCtD
Dasatinib—Connective tissue disorder—Metformin—metabolic syndrome X	0.000465	0.0168	CcSEcCtD
Dasatinib—FMO3—liver—metabolic syndrome X	0.000454	0.00413	CbGeAlD
Dasatinib—EPHB4—liver—metabolic syndrome X	0.000447	0.00407	CbGeAlD
Dasatinib—JAK2—liver—metabolic syndrome X	0.000444	0.00404	CbGeAlD
Dasatinib—Eye disorder—Metformin—metabolic syndrome X	0.000443	0.0159	CcSEcCtD
Dasatinib—KIT—adipose tissue—metabolic syndrome X	0.000442	0.00402	CbGeAlD
Dasatinib—Cardiac disorder—Metformin—metabolic syndrome X	0.00044	0.0158	CcSEcCtD
Dasatinib—Flushing—Metformin—metabolic syndrome X	0.00044	0.0158	CcSEcCtD
Dasatinib—EPHA2—liver—metabolic syndrome X	0.000439	0.00399	CbGeAlD
Dasatinib—FYN—liver—metabolic syndrome X	0.000438	0.00398	CbGeAlD
Dasatinib—ABL1—cardiovascular system—metabolic syndrome X	0.000436	0.00397	CbGeAlD
Dasatinib—PDGFRB—adipose tissue—metabolic syndrome X	0.000432	0.00392	CbGeAlD
Dasatinib—Angiopathy—Metformin—metabolic syndrome X	0.00043	0.0155	CcSEcCtD
Dasatinib—MAP3K3—liver—metabolic syndrome X	0.000428	0.00389	CbGeAlD
Dasatinib—MAP4K5—liver—metabolic syndrome X	0.000428	0.00389	CbGeAlD
Dasatinib—Immune system disorder—Metformin—metabolic syndrome X	0.000428	0.0154	CcSEcCtD
Dasatinib—ABL1—kidney—metabolic syndrome X	0.000427	0.00388	CbGeAlD
Dasatinib—Mediastinal disorder—Metformin—metabolic syndrome X	0.000427	0.0154	CcSEcCtD
Dasatinib—Chills—Metformin—metabolic syndrome X	0.000425	0.0153	CcSEcCtD
Dasatinib—Malnutrition—Metformin—metabolic syndrome X	0.000412	0.0148	CcSEcCtD
Dasatinib—Erythema—Metformin—metabolic syndrome X	0.000412	0.0148	CcSEcCtD
Dasatinib—Dysgeusia—Metformin—metabolic syndrome X	0.000404	0.0145	CcSEcCtD
Dasatinib—Muscle spasms—Metformin—metabolic syndrome X	0.000396	0.0143	CcSEcCtD
Dasatinib—YES1—liver—metabolic syndrome X	0.000395	0.00359	CbGeAlD
Dasatinib—Vision blurred—Metformin—metabolic syndrome X	0.000389	0.014	CcSEcCtD
Dasatinib—PDGFRA—liver—metabolic syndrome X	0.000388	0.00353	CbGeAlD
Dasatinib—Tremor—Metformin—metabolic syndrome X	0.000386	0.0139	CcSEcCtD
Dasatinib—ABL1—adipose tissue—metabolic syndrome X	0.000385	0.0035	CbGeAlD
Dasatinib—Ill-defined disorder—Metformin—metabolic syndrome X	0.000383	0.0138	CcSEcCtD
Dasatinib—SRC—liver—metabolic syndrome X	0.00038	0.00346	CbGeAlD
Dasatinib—Malaise—Metformin—metabolic syndrome X	0.000372	0.0134	CcSEcCtD
Dasatinib—Syncope—Metformin—metabolic syndrome X	0.00037	0.0133	CcSEcCtD
Dasatinib—CYP1B1—cardiovascular system—metabolic syndrome X	0.00037	0.00336	CbGeAlD
Dasatinib—Palpitations—Metformin—metabolic syndrome X	0.000364	0.0131	CcSEcCtD
Dasatinib—Loss of consciousness—Metformin—metabolic syndrome X	0.000362	0.013	CcSEcCtD
Dasatinib—CYP1B1—kidney—metabolic syndrome X	0.000362	0.00329	CbGeAlD
Dasatinib—Hypertension—Metformin—metabolic syndrome X	0.000356	0.0128	CcSEcCtD
Dasatinib—Myalgia—Metformin—metabolic syndrome X	0.000351	0.0126	CcSEcCtD
Dasatinib—Chest pain—Metformin—metabolic syndrome X	0.000351	0.0126	CcSEcCtD
Dasatinib—MAP2K5—liver—metabolic syndrome X	0.00035	0.00318	CbGeAlD
Dasatinib—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.000349	0.0125	CcSEcCtD
Dasatinib—Discomfort—Metformin—metabolic syndrome X	0.000347	0.0125	CcSEcCtD
Dasatinib—CSF1R—liver—metabolic syndrome X	0.000341	0.0031	CbGeAlD
Dasatinib—Oedema—Metformin—metabolic syndrome X	0.000337	0.0121	CcSEcCtD
Dasatinib—Infection—Metformin—metabolic syndrome X	0.000334	0.012	CcSEcCtD
Dasatinib—Shock—Metformin—metabolic syndrome X	0.000331	0.0119	CcSEcCtD
Dasatinib—Nervous system disorder—Metformin—metabolic syndrome X	0.00033	0.0119	CcSEcCtD
Dasatinib—Thrombocytopenia—Metformin—metabolic syndrome X	0.000329	0.0119	CcSEcCtD
Dasatinib—Skin disorder—Metformin—metabolic syndrome X	0.000327	0.0118	CcSEcCtD
Dasatinib—CYP1B1—adipose tissue—metabolic syndrome X	0.000326	0.00296	CbGeAlD
Dasatinib—Hyperhidrosis—Metformin—metabolic syndrome X	0.000325	0.0117	CcSEcCtD
Dasatinib—Anorexia—Metformin—metabolic syndrome X	0.000321	0.0115	CcSEcCtD
Dasatinib—Hypotension—Metformin—metabolic syndrome X	0.000314	0.0113	CcSEcCtD
Dasatinib—KIT—liver—metabolic syndrome X	0.00031	0.00282	CbGeAlD
Dasatinib—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.000307	0.011	CcSEcCtD
Dasatinib—ABCB1—blood vessel—metabolic syndrome X	0.000304	0.00277	CbGeAlD
Dasatinib—PDGFRB—liver—metabolic syndrome X	0.000303	0.00275	CbGeAlD
Dasatinib—Dyspnoea—Metformin—metabolic syndrome X	0.0003	0.0108	CcSEcCtD
Dasatinib—Somnolence—Metformin—metabolic syndrome X	0.000299	0.0108	CcSEcCtD
Dasatinib—Dyspepsia—Metformin—metabolic syndrome X	0.000296	0.0107	CcSEcCtD
Dasatinib—Decreased appetite—Metformin—metabolic syndrome X	0.000293	0.0105	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.000291	0.0105	CcSEcCtD
Dasatinib—Fatigue—Metformin—metabolic syndrome X	0.00029	0.0104	CcSEcCtD
Dasatinib—Constipation—Metformin—metabolic syndrome X	0.000288	0.0104	CcSEcCtD
Dasatinib—Feeling abnormal—Metformin—metabolic syndrome X	0.000277	0.00998	CcSEcCtD
Dasatinib—Gastrointestinal pain—Metformin—metabolic syndrome X	0.000275	0.0099	CcSEcCtD
Dasatinib—ABL1—liver—metabolic syndrome X	0.00027	0.00245	CbGeAlD
Dasatinib—Urticaria—Metformin—metabolic syndrome X	0.000267	0.00962	CcSEcCtD
Dasatinib—Abdominal pain—Metformin—metabolic syndrome X	0.000266	0.00957	CcSEcCtD
Dasatinib—CYP1A1—kidney—metabolic syndrome X	0.000256	0.00232	CbGeAlD
Dasatinib—CYP3A5—kidney—metabolic syndrome X	0.00025	0.00227	CbGeAlD
Dasatinib—ABCG2—adipose tissue—metabolic syndrome X	0.000243	0.00221	CbGeAlD
Dasatinib—Asthenia—Metformin—metabolic syndrome X	0.000241	0.00869	CcSEcCtD
Dasatinib—Pruritus—Metformin—metabolic syndrome X	0.000238	0.00857	CcSEcCtD
Dasatinib—CYP1A1—adipose tissue—metabolic syndrome X	0.00023	0.00209	CbGeAlD
Dasatinib—Diarrhoea—Metformin—metabolic syndrome X	0.00023	0.00829	CcSEcCtD
Dasatinib—CYP1B1—liver—metabolic syndrome X	0.000229	0.00208	CbGeAlD
Dasatinib—CYP3A5—adipose tissue—metabolic syndrome X	0.000225	0.00205	CbGeAlD
Dasatinib—Dizziness—Metformin—metabolic syndrome X	0.000223	0.00801	CcSEcCtD
Dasatinib—Vomiting—Metformin—metabolic syndrome X	0.000214	0.0077	CcSEcCtD
Dasatinib—Rash—Metformin—metabolic syndrome X	0.000212	0.00764	CcSEcCtD
Dasatinib—Dermatitis—Metformin—metabolic syndrome X	0.000212	0.00763	CcSEcCtD
Dasatinib—Headache—Metformin—metabolic syndrome X	0.000211	0.00759	CcSEcCtD
Dasatinib—Nausea—Metformin—metabolic syndrome X	0.0002	0.00719	CcSEcCtD
Dasatinib—CYP3A4—kidney—metabolic syndrome X	0.000188	0.00171	CbGeAlD
Dasatinib—ABCG2—liver—metabolic syndrome X	0.00017	0.00155	CbGeAlD
Dasatinib—CYP1A2—liver—metabolic syndrome X	0.000164	0.00149	CbGeAlD
Dasatinib—CYP1A1—liver—metabolic syndrome X	0.000162	0.00147	CbGeAlD
Dasatinib—CYP3A5—liver—metabolic syndrome X	0.000158	0.00144	CbGeAlD
Dasatinib—ABCB1—cardiovascular system—metabolic syndrome X	0.000136	0.00123	CbGeAlD
Dasatinib—ABCB1—kidney—metabolic syndrome X	0.000133	0.00121	CbGeAlD
Dasatinib—ABCB1—adipose tissue—metabolic syndrome X	0.00012	0.00109	CbGeAlD
Dasatinib—CYP3A4—liver—metabolic syndrome X	0.000119	0.00108	CbGeAlD
Dasatinib—ABCB1—liver—metabolic syndrome X	8.39e-05	0.000763	CbGeAlD
Dasatinib—ERBB3—Disease—IL6—metabolic syndrome X	3.69e-06	2.12e-05	CbGpPWpGaD
Dasatinib—ERBB3—Immune System—AKT1—metabolic syndrome X	3.69e-06	2.12e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—IGF1—metabolic syndrome X	3.68e-06	2.12e-05	CbGpPWpGaD
Dasatinib—SRC—Disease—SERPINE1—metabolic syndrome X	3.68e-06	2.12e-05	CbGpPWpGaD
Dasatinib—LCK—Innate Immune System—IL6—metabolic syndrome X	3.68e-06	2.12e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—LPL—metabolic syndrome X	3.68e-06	2.11e-05	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—INS—metabolic syndrome X	3.67e-06	2.11e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—APOA1—metabolic syndrome X	3.67e-06	2.11e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—INS—metabolic syndrome X	3.67e-06	2.11e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—NAMPT—metabolic syndrome X	3.65e-06	2.1e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—APOB—metabolic syndrome X	3.64e-06	2.09e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—TGFB1—metabolic syndrome X	3.63e-06	2.09e-05	CbGpPWpGaD
Dasatinib—LCK—Disease—PTGS2—metabolic syndrome X	3.63e-06	2.09e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	3.63e-06	2.09e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—SERPINE1—metabolic syndrome X	3.63e-06	2.09e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—LIPC—metabolic syndrome X	3.63e-06	2.09e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—GCK—metabolic syndrome X	3.63e-06	2.09e-05	CbGpPWpGaD
Dasatinib—FMO3—Metabolism—AKT1—metabolic syndrome X	3.63e-06	2.09e-05	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—AKT1—metabolic syndrome X	3.62e-06	2.08e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—INS—metabolic syndrome X	3.62e-06	2.08e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—CCL2—metabolic syndrome X	3.61e-06	2.08e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—HDAC3—metabolic syndrome X	3.61e-06	2.07e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—APOC3—metabolic syndrome X	3.61e-06	2.07e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—CCL2—metabolic syndrome X	3.56e-06	2.05e-05	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—TGFB1—metabolic syndrome X	3.56e-06	2.05e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—SERPINE1—metabolic syndrome X	3.55e-06	2.04e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—IGF1—metabolic syndrome X	3.55e-06	2.04e-05	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—NOS3—metabolic syndrome X	3.54e-06	2.04e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—PLA2G4A—metabolic syndrome X	3.54e-06	2.04e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—SLC2A4—metabolic syndrome X	3.54e-06	2.03e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—ABCA1—metabolic syndrome X	3.54e-06	2.03e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—GCKR—metabolic syndrome X	3.53e-06	2.03e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—LPA—metabolic syndrome X	3.53e-06	2.03e-05	CbGpPWpGaD
Dasatinib—SRC—Disease—NOS3—metabolic syndrome X	3.52e-06	2.02e-05	CbGpPWpGaD
Dasatinib—YES1—Immune System—IL6—metabolic syndrome X	3.51e-06	2.02e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—IGF1—metabolic syndrome X	3.5e-06	2.01e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—CETP—metabolic syndrome X	3.5e-06	2.01e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—SERPINE1—metabolic syndrome X	3.5e-06	2.01e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—CD36—metabolic syndrome X	3.49e-06	2.01e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—LPL—metabolic syndrome X	3.47e-06	2e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—NOS3—metabolic syndrome X	3.47e-06	1.99e-05	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—TGFB1—metabolic syndrome X	3.43e-06	1.97e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—GOT1—metabolic syndrome X	3.42e-06	1.97e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—GGT1—metabolic syndrome X	3.42e-06	1.97e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—PLA2G6—metabolic syndrome X	3.41e-06	1.96e-05	CbGpPWpGaD
Dasatinib—SRC—Developmental Biology—AKT1—metabolic syndrome X	3.4e-06	1.96e-05	CbGpPWpGaD
Dasatinib—ERBB3—Disease—AKT1—metabolic syndrome X	3.4e-06	1.96e-05	CbGpPWpGaD
Dasatinib—LCK—Innate Immune System—AKT1—metabolic syndrome X	3.4e-06	1.95e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—NOS3—metabolic syndrome X	3.39e-06	1.95e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—APOA5—metabolic syndrome X	3.38e-06	1.94e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—SERPINE1—metabolic syndrome X	3.37e-06	1.94e-05	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—ALB—metabolic syndrome X	3.37e-06	1.94e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—AGT—metabolic syndrome X	3.35e-06	1.93e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—SCARB1—metabolic syndrome X	3.35e-06	1.93e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—NOS3—metabolic syndrome X	3.34e-06	1.92e-05	CbGpPWpGaD
Dasatinib—SRC—Hemostasis—AKT1—metabolic syndrome X	3.34e-06	1.92e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—SERPINE1—metabolic syndrome X	3.33e-06	1.91e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—IRS1—metabolic syndrome X	3.31e-06	1.9e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—CD36—metabolic syndrome X	3.3e-06	1.9e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—APOE—metabolic syndrome X	3.29e-06	1.89e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—LEP—metabolic syndrome X	3.29e-06	1.89e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—TGFB1—metabolic syndrome X	3.27e-06	1.88e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	3.26e-06	1.88e-05	CbGpPWpGaD
Dasatinib—LCK—Adaptive Immune System—AKT1—metabolic syndrome X	3.26e-06	1.88e-05	CbGpPWpGaD
Dasatinib—SRC—Innate Immune System—IL6—metabolic syndrome X	3.26e-06	1.87e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—SREBF1—metabolic syndrome X	3.26e-06	1.87e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—APOA1—metabolic syndrome X	3.25e-06	1.87e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—PPARA—metabolic syndrome X	3.25e-06	1.87e-05	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—PTGS2—metabolic syndrome X	3.24e-06	1.86e-05	CbGpPWpGaD
Dasatinib—YES1—Immune System—AKT1—metabolic syndrome X	3.24e-06	1.86e-05	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—NOS3—metabolic syndrome X	3.22e-06	1.85e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—NOS3—metabolic syndrome X	3.22e-06	1.85e-05	CbGpPWpGaD
Dasatinib—SRC—Disease—PTGS2—metabolic syndrome X	3.22e-06	1.85e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—NOS3—metabolic syndrome X	3.18e-06	1.83e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—INS—metabolic syndrome X	3.17e-06	1.82e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—GOT2—metabolic syndrome X	3.17e-06	1.82e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—HMGCR—metabolic syndrome X	3.17e-06	1.82e-05	CbGpPWpGaD
Dasatinib—FYN—Disease—TGFB1—metabolic syndrome X	3.15e-06	1.81e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—AGT—metabolic syndrome X	3.15e-06	1.81e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—TRIB3—metabolic syndrome X	3.14e-06	1.81e-05	CbGpPWpGaD
Dasatinib—KIT—Immune System—IL6—metabolic syndrome X	3.13e-06	1.8e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—CCL2—metabolic syndrome X	3.12e-06	1.79e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—APOE—metabolic syndrome X	3.08e-06	1.77e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—PPARA—metabolic syndrome X	3.07e-06	1.76e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—IGF1—metabolic syndrome X	3.07e-06	1.76e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—APOA1—metabolic syndrome X	3.05e-06	1.75e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—TGFB1—metabolic syndrome X	3.01e-06	1.73e-05	CbGpPWpGaD
Dasatinib—SRC—Innate Immune System—AKT1—metabolic syndrome X	3.01e-06	1.73e-05	CbGpPWpGaD
Dasatinib—JAK2—Disease—TGFB1—metabolic syndrome X	3e-06	1.72e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—AGT—metabolic syndrome X	2.97e-06	1.71e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—IL6—metabolic syndrome X	2.96e-06	1.71e-05	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—PTGS2—metabolic syndrome X	2.95e-06	1.7e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—IRS1—metabolic syndrome X	2.93e-06	1.69e-05	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—IL6—metabolic syndrome X	2.93e-06	1.69e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—SERPINE1—metabolic syndrome X	2.91e-06	1.68e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—APOE—metabolic syndrome X	2.91e-06	1.67e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—APOB—metabolic syndrome X	2.91e-06	1.67e-05	CbGpPWpGaD
Dasatinib—KIT—Disease—IL6—metabolic syndrome X	2.89e-06	1.66e-05	CbGpPWpGaD
Dasatinib—KIT—Immune System—AKT1—metabolic syndrome X	2.89e-06	1.66e-05	CbGpPWpGaD
Dasatinib—SRC—Adaptive Immune System—AKT1—metabolic syndrome X	2.89e-06	1.66e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—APOA1—metabolic syndrome X	2.88e-06	1.66e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	2.86e-06	1.64e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—PLA2G4A—metabolic syndrome X	2.83e-06	1.63e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—SLC2A4—metabolic syndrome X	2.82e-06	1.62e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—ABCA1—metabolic syndrome X	2.82e-06	1.62e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—NAMPT—metabolic syndrome X	2.82e-06	1.62e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—INS—metabolic syndrome X	2.81e-06	1.61e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—LIPC—metabolic syndrome X	2.8e-06	1.61e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—GCK—metabolic syndrome X	2.8e-06	1.61e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—APOC3—metabolic syndrome X	2.78e-06	1.6e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—NOS3—metabolic syndrome X	2.78e-06	1.6e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—LPL—metabolic syndrome X	2.77e-06	1.6e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CCL2—metabolic syndrome X	2.76e-06	1.59e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—IL6—metabolic syndrome X	2.74e-06	1.57e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—AKT1—metabolic syndrome X	2.74e-06	1.57e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—GOT1—metabolic syndrome X	2.73e-06	1.57e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—GGT1—metabolic syndrome X	2.73e-06	1.57e-05	CbGpPWpGaD
Dasatinib—JAK2—GPCR downstream signaling—AKT1—metabolic syndrome X	2.72e-06	1.57e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—IGF1—metabolic syndrome X	2.72e-06	1.56e-05	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—AKT1—metabolic syndrome X	2.7e-06	1.55e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—CETP—metabolic syndrome X	2.7e-06	1.55e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—TGFB1—metabolic syndrome X	2.69e-06	1.55e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—PPARG—metabolic syndrome X	2.68e-06	1.54e-05	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—IL6—metabolic syndrome X	2.68e-06	1.54e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—IL6—metabolic syndrome X	2.68e-06	1.54e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—IL6—metabolic syndrome X	2.67e-06	1.54e-05	CbGpPWpGaD
Dasatinib—KIT—Disease—AKT1—metabolic syndrome X	2.67e-06	1.53e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—CD36—metabolic syndrome X	2.64e-06	1.52e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—INS—metabolic syndrome X	2.63e-06	1.51e-05	CbGpPWpGaD
Dasatinib—LCK—Disease—TGFB1—metabolic syndrome X	2.63e-06	1.51e-05	CbGpPWpGaD
Dasatinib—LYN—Immune System—IL6—metabolic syndrome X	2.62e-06	1.5e-05	CbGpPWpGaD
Dasatinib—ABL1—Immune System—IL6—metabolic syndrome X	2.6e-06	1.5e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	2.59e-06	1.49e-05	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—IL6—metabolic syndrome X	2.58e-06	1.49e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—SERPINE1—metabolic syndrome X	2.58e-06	1.48e-05	CbGpPWpGaD
Dasatinib—FYN—Immune System—IL6—metabolic syndrome X	2.57e-06	1.48e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—TGFB1—metabolic syndrome X	2.54e-06	1.46e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—PPARG—metabolic syndrome X	2.54e-06	1.46e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—AKT1—metabolic syndrome X	2.53e-06	1.45e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	2.51e-06	1.44e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—INS—metabolic syndrome X	2.49e-06	1.43e-05	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—IL6—metabolic syndrome X	2.48e-06	1.43e-05	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—AKT1—metabolic syndrome X	2.47e-06	1.42e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—AKT1—metabolic syndrome X	2.47e-06	1.42e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—IL6—metabolic syndrome X	2.47e-06	1.42e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—AKT1—metabolic syndrome X	2.46e-06	1.42e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—NOS3—metabolic syndrome X	2.46e-06	1.42e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—PPARA—metabolic syndrome X	2.45e-06	1.41e-05	CbGpPWpGaD
Dasatinib—JAK2—Immune System—IL6—metabolic syndrome X	2.45e-06	1.41e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—GOT2—metabolic syndrome X	2.44e-06	1.41e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	2.44e-06	1.41e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—ALB—metabolic syndrome X	2.41e-06	1.39e-05	CbGpPWpGaD
Dasatinib—LYN—Immune System—AKT1—metabolic syndrome X	2.41e-06	1.39e-05	CbGpPWpGaD
Dasatinib—ABL1—Immune System—AKT1—metabolic syndrome X	2.4e-06	1.38e-05	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—AKT1—metabolic syndrome X	2.38e-06	1.37e-05	CbGpPWpGaD
Dasatinib—FYN—Disease—IL6—metabolic syndrome X	2.38e-06	1.37e-05	CbGpPWpGaD
Dasatinib—FYN—Immune System—AKT1—metabolic syndrome X	2.38e-06	1.37e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—AGT—metabolic syndrome X	2.37e-06	1.37e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—APOE—metabolic syndrome X	2.33e-06	1.34e-05	CbGpPWpGaD
Dasatinib—SRC—Disease—TGFB1—metabolic syndrome X	2.33e-06	1.34e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—APOB—metabolic syndrome X	2.32e-06	1.33e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—NOS3—metabolic syndrome X	2.31e-06	1.33e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—APOA1—metabolic syndrome X	2.3e-06	1.32e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—TGFB1—metabolic syndrome X	2.29e-06	1.32e-05	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—AKT1—metabolic syndrome X	2.29e-06	1.32e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—ALB—metabolic syndrome X	2.28e-06	1.31e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—AKT1—metabolic syndrome X	2.28e-06	1.31e-05	CbGpPWpGaD
Dasatinib—MAPK14—Gene Expression—AKT1—metabolic syndrome X	2.27e-06	1.31e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—IL6—metabolic syndrome X	2.27e-06	1.3e-05	CbGpPWpGaD
Dasatinib—JAK2—Disease—IL6—metabolic syndrome X	2.26e-06	1.3e-05	CbGpPWpGaD
Dasatinib—JAK2—Immune System—AKT1—metabolic syndrome X	2.26e-06	1.3e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—PLA2G4A—metabolic syndrome X	2.26e-06	1.3e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—TGFB1—metabolic syndrome X	2.24e-06	1.29e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—LPL—metabolic syndrome X	2.21e-06	1.27e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—TGFB1—metabolic syndrome X	2.21e-06	1.27e-05	CbGpPWpGaD
Dasatinib—FYN—Disease—AKT1—metabolic syndrome X	2.19e-06	1.26e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—NOS3—metabolic syndrome X	2.18e-06	1.25e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	2.18e-06	1.25e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	2.18e-06	1.25e-05	CbGpPWpGaD
Dasatinib—LCK—Immune System—IL6—metabolic syndrome X	2.14e-06	1.23e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—TGFB1—metabolic syndrome X	2.13e-06	1.22e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—PTGS2—metabolic syndrome X	2.11e-06	1.21e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—GOT1—metabolic syndrome X	2.11e-06	1.21e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—GGT1—metabolic syndrome X	2.11e-06	1.21e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—CD36—metabolic syndrome X	2.1e-06	1.21e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—TGFB1—metabolic syndrome X	2.1e-06	1.21e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—AKT1—metabolic syndrome X	2.09e-06	1.2e-05	CbGpPWpGaD
Dasatinib—JAK2—Disease—AKT1—metabolic syndrome X	2.08e-06	1.2e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—PPARG—metabolic syndrome X	2.03e-06	1.17e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—IL6—metabolic syndrome X	2.03e-06	1.16e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—PTGS2—metabolic syndrome X	2e-06	1.15e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—INS—metabolic syndrome X	1.99e-06	1.14e-05	CbGpPWpGaD
Dasatinib—LCK—Disease—IL6—metabolic syndrome X	1.98e-06	1.14e-05	CbGpPWpGaD
Dasatinib—LCK—Immune System—AKT1—metabolic syndrome X	1.98e-06	1.14e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—PPARA—metabolic syndrome X	1.96e-06	1.13e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—IL6—metabolic syndrome X	1.92e-06	1.1e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—IL6—metabolic syndrome X	1.9e-06	1.09e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—AGT—metabolic syndrome X	1.89e-06	1.09e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—AKT1—metabolic syndrome X	1.87e-06	1.07e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—APOE—metabolic syndrome X	1.86e-06	1.07e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—TGFB1—metabolic syndrome X	1.84e-06	1.06e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—APOA1—metabolic syndrome X	1.84e-06	1.06e-05	CbGpPWpGaD
Dasatinib—LCK—Disease—AKT1—metabolic syndrome X	1.83e-06	1.05e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—ALB—metabolic syndrome X	1.82e-06	1.05e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—APOB—metabolic syndrome X	1.79e-06	1.03e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—AKT1—metabolic syndrome X	1.77e-06	1.02e-05	CbGpPWpGaD
Dasatinib—SRC—Disease—IL6—metabolic syndrome X	1.75e-06	1.01e-05	CbGpPWpGaD
Dasatinib—SRC—Immune System—AKT1—metabolic syndrome X	1.75e-06	1.01e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—NOS3—metabolic syndrome X	1.74e-06	1e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	1.74e-06	1e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—IL6—metabolic syndrome X	1.73e-06	9.93e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—LPL—metabolic syndrome X	1.71e-06	9.83e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—IL6—metabolic syndrome X	1.69e-06	9.72e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—IL6—metabolic syndrome X	1.66e-06	9.57e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—TGFB1—metabolic syndrome X	1.63e-06	9.36e-06	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—AKT1—metabolic syndrome X	1.63e-06	9.36e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—CD36—metabolic syndrome X	1.62e-06	9.34e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—PPARG—metabolic syndrome X	1.62e-06	9.3e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—AKT1—metabolic syndrome X	1.62e-06	9.3e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—IL6—metabolic syndrome X	1.6e-06	9.22e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—PTGS2—metabolic syndrome X	1.59e-06	9.16e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—AKT1—metabolic syndrome X	1.59e-06	9.16e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—INS—metabolic syndrome X	1.59e-06	9.12e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—IL6—metabolic syndrome X	1.58e-06	9.1e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—AKT1—metabolic syndrome X	1.56e-06	8.97e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—AKT1—metabolic syndrome X	1.54e-06	8.83e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—PPARA—metabolic syndrome X	1.51e-06	8.68e-06	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—AKT1—metabolic syndrome X	1.48e-06	8.52e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—AKT1—metabolic syndrome X	1.48e-06	8.51e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—AGT—metabolic syndrome X	1.46e-06	8.41e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—AKT1—metabolic syndrome X	1.46e-06	8.4e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—ALB—metabolic syndrome X	1.45e-06	8.36e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—APOE—metabolic syndrome X	1.43e-06	8.24e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—APOA1—metabolic syndrome X	1.42e-06	8.15e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—NOS3—metabolic syndrome X	1.39e-06	8e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—IL6—metabolic syndrome X	1.39e-06	7.97e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—AKT1—metabolic syndrome X	1.28e-06	7.35e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—PTGS2—metabolic syndrome X	1.27e-06	7.32e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—PPARG—metabolic syndrome X	1.25e-06	7.18e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—IL6—metabolic syndrome X	1.23e-06	7.06e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—INS—metabolic syndrome X	1.22e-06	7.04e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—AKT1—metabolic syndrome X	1.13e-06	6.51e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—ALB—metabolic syndrome X	1.12e-06	6.45e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—NOS3—metabolic syndrome X	1.07e-06	6.17e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—AKT1—metabolic syndrome X	1.06e-06	6.1e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—AKT1—metabolic syndrome X	1e-06	5.77e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	9.82e-07	5.65e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—AKT1—metabolic syndrome X	8.01e-07	4.61e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—AKT1—metabolic syndrome X	6.39e-07	3.68e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—AKT1—metabolic syndrome X	4.93e-07	2.84e-06	CbGpPWpGaD
